SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Terce Laboratories launches Acolate Plus Tablet

15 Feb 2019 Evaluate

Gujarat Terce Laboratories has launched product i.e. Acolate Plus Tablet on February 15, 2019 at Ahmedabad, India.  Acolate plus is a line extension decision. This formula is most awaited to complete the product  basket for Acolate Brand. The formula is most preferable & widely accepted. Therapeutically Acolate plus is capturing the segment of cetirizine preferred audience. Product will cater & nurture the existing base of Acolate brand.

Gujarat Terce Laboratories is engaged in the manufacturing of tablets, capsules, syrup and injections pertaining to the product group, pharmaceutical formulations and ayurvedic medicines.

Gujarat Terce Labs. Share Price

33.35 -0.42 (-1.24%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: